| Type 2 Diabetes Mellitus |
1 |
1 |
| Obesity |
0 |
0.93 |
| Weight Loss |
0 |
0.99 |
| Weight Management |
0 |
0.98 |
| Bariatric Surgery |
0 |
0.77 |
| GLP-1 Receptor Agonist |
0 |
0.2 |
| Europe |
0 |
0.14 |
| Incretin Hormone |
0 |
0.14 |
| Receptors |
0 |
0.14 |
| Remission |
0 |
0.14 |
| Surgery |
0 |
0.14 |
| Blood |
0 |
0.09 |
| Endocrinology |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.07 |
| Cardiovascular Risk Management |
0 |
0.06 |
| Cardiovascular disease |
0 |
0.05 |
| Clinical Guidelines |
0 |
0.05 |
| Health Care Quality, Access, and Evaluation |
0 |
0.05 |
| Heart |
0 |
0.05 |
| Hyperglycemia |
0 |
0.05 |
| Metabolism |
0 |
0.05 |
| Professional Development |
0 |
0.05 |
| Professional Practice |
0 |
0.05 |
| Psychology |
0 |
0.05 |
| Texas |
0 |
0.05 |
| UK Site Content |
0 |
0.05 |
| Social Determinants of Health |
0 |
0.04 |